Assessment of Frailty Can Guide Decision Making for Utilization of Sentinel Lymph Node Biopsy in Patients with Thick Melanoma.

Avinash S SharmaJessica R FlynnKatherine S PanageasArmin ShahrokniAmy L TinDanielle M BelloCharlotte E AriyanMary Sue BradyDaniel G CoitMadalyn G Neuwirth

Published in: Annals of surgical oncology (2021)

We observed worse OS in patients with thick melanoma selected not to undergo SLNB, which was attributed to death due to non-melanoma causes. Formal assessment of frailty may provide an objective prognostic measure to guide selective use of SLNB in these patients.

Keyphrases

sentinel lymph node
end stage renal disease
decision making
ejection fraction
newly diagnosed
lymph node
chronic kidney disease
early stage
prognostic factors
basal cell carcinoma
squamous cell carcinoma
radiation therapy
community dwelling
patient reported outcomes
ultrasound guided
clinical evaluation